Answers are grounded in this paper and cite their sources.
The characterization of multiple P1-type nucleoside transport activities in T. brucei brucei facilitates the development of nucleoside-based treatments for African trypanosomiasis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2014) studied African trypanosomiasis. TbNT9/AT-D and NT10/AT-B nucleoside transporters was evaluated on Transporter binding and affinity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: